Endobronchial ultrasound in diagnosing and staging of lung cancer by Acquire 22G TBNB versus regular 22G TBNA needles: A randomized clinical trial
•The PD-L1 suitability rate between the 22G Acquire TBNB and Expect TBNA needle is similar.•Both needles have high sensitivities for diagnosing and staging lung cancer.•Acquire TBNB needle procures improved quality tissue specimens with more tissue cores. Endobronchial ultrasound guided transbronchi...
Saved in:
| Published in: | Lung cancer (Amsterdam, Netherlands) Vol. 185; p. 107362 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Elsevier B.V
01.11.2023
|
| Subjects: | |
| ISSN: | 0169-5002, 1872-8332, 1872-8332 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | •The PD-L1 suitability rate between the 22G Acquire TBNB and Expect TBNA needle is similar.•Both needles have high sensitivities for diagnosing and staging lung cancer.•Acquire TBNB needle procures improved quality tissue specimens with more tissue cores.
Endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) has an important role in the diagnosis and staging of lung cancer. Evaluation of programmed death ligand 1 (PD-L1) expression and molecular profiling has become standard of care but cytological samples frequently contain insufficient tumor cells. The 22G Acquire needle with Franseen needle tip was developed to perform transbronchial needle biopsy (TBNB) with improved tissue specimens. This study evaluated if the 22G Acquire TBNB needle results in enhanced PD-L1 suitability rate compared to the regular Expect 22G TBNA needle.
in this multi-center randomized clinical trial (Netherlands Trial Register NL7701), patients with suspected (N)SCLC and an indication for mediastinal/hilar staging or lung tumor diagnosis were recruited in five university and general hospitals in the Netherlands, Poland, Italy and Czech Republic. Patients were randomized (1:1) between the two needles. Two blinded reference pathologists evaluated the samples. The primary outcome was PD-L1 suitability rate in patients with a final diagnosis of lung cancer. In case no malignancy was diagnosed, the reference standard was surgical verification or 6 month follow-up.
154 patients were randomized (n = 76 Acquire TBNB; n = 78 Expect TBNA) of which 92.9% (n = 143) had a final malignant diagnosis. Suitability for PD-L1 analysis was 80.0% (n = 56/70; 95 %CI 0.68–0.94) with the Acquire needle and 76.7% (n = 56/73; 95 %CI 0.65–0.85) with the Expect needle (p = 0.633). Acquire TBNB needle specimens provided more frequent superior quality (65.3% (95 %CI 0.57–0.73) vs 49.4% (95 %CI 0.41–0.57, p = 0.005) and contained more tissue cores (72.0% (95 %CI 0.60-0.81) vs 41.0% (95 %CI 0.31–0.54, p < 0.01). There were no statistically significant differences in tissue adequacy, suitability for molecular analysis and sensitivity for malignancy and N2/N3 disease.
The 22G Acquire TBNB needle procured improved quality tissue specimens compared to the Expect TBNA needle but this did not result in an improved the suitability rate for PD-L1 analysis. |
|---|---|
| AbstractList | Endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) has an important role in the diagnosis and staging of lung cancer. Evaluation of programmed death ligand 1 (PD-L1) expression and molecular profiling has become standard of care but cytological samples frequently contain insufficient tumor cells. The 22G Acquire needle with Franseen needle tip was developed to perform transbronchial needle biopsy (TBNB) with improved tissue specimens. This study evaluated if the 22G Acquire TBNB needle results in enhanced PD-L1 suitability rate compared to the regular Expect 22G TBNA needle.OBJECTIVESEndobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) has an important role in the diagnosis and staging of lung cancer. Evaluation of programmed death ligand 1 (PD-L1) expression and molecular profiling has become standard of care but cytological samples frequently contain insufficient tumor cells. The 22G Acquire needle with Franseen needle tip was developed to perform transbronchial needle biopsy (TBNB) with improved tissue specimens. This study evaluated if the 22G Acquire TBNB needle results in enhanced PD-L1 suitability rate compared to the regular Expect 22G TBNA needle.in this multi-center randomized clinical trial (Netherlands Trial Register NL7701), patients with suspected (N)SCLC and an indication for mediastinal/hilar staging or lung tumor diagnosis were recruited in five university and general hospitals in the Netherlands, Poland, Italy and Czech Republic. Patients were randomized (1:1) between the two needles. Two blinded reference pathologists evaluated the samples. The primary outcome was PD-L1 suitability rate in patients with a final diagnosis of lung cancer. In case no malignancy was diagnosed, the reference standard was surgical verification or 6 month follow-up.METHODSin this multi-center randomized clinical trial (Netherlands Trial Register NL7701), patients with suspected (N)SCLC and an indication for mediastinal/hilar staging or lung tumor diagnosis were recruited in five university and general hospitals in the Netherlands, Poland, Italy and Czech Republic. Patients were randomized (1:1) between the two needles. Two blinded reference pathologists evaluated the samples. The primary outcome was PD-L1 suitability rate in patients with a final diagnosis of lung cancer. In case no malignancy was diagnosed, the reference standard was surgical verification or 6 month follow-up.154 patients were randomized (n = 76 Acquire TBNB; n = 78 Expect TBNA) of which 92.9% (n = 143) had a final malignant diagnosis. Suitability for PD-L1 analysis was 80.0% (n = 56/70; 95 %CI 0.68-0.94) with the Acquire needle and 76.7% (n = 56/73; 95 %CI 0.65-0.85) with the Expect needle (p = 0.633). Acquire TBNB needle specimens provided more frequent superior quality (65.3% (95 %CI 0.57-0.73) vs 49.4% (95 %CI 0.41-0.57, p = 0.005) and contained more tissue cores (72.0% (95 %CI 0.60-0.81) vs 41.0% (95 %CI 0.31-0.54, p < 0.01). There were no statistically significant differences in tissue adequacy, suitability for molecular analysis and sensitivity for malignancy and N2/N3 disease.RESULTS154 patients were randomized (n = 76 Acquire TBNB; n = 78 Expect TBNA) of which 92.9% (n = 143) had a final malignant diagnosis. Suitability for PD-L1 analysis was 80.0% (n = 56/70; 95 %CI 0.68-0.94) with the Acquire needle and 76.7% (n = 56/73; 95 %CI 0.65-0.85) with the Expect needle (p = 0.633). Acquire TBNB needle specimens provided more frequent superior quality (65.3% (95 %CI 0.57-0.73) vs 49.4% (95 %CI 0.41-0.57, p = 0.005) and contained more tissue cores (72.0% (95 %CI 0.60-0.81) vs 41.0% (95 %CI 0.31-0.54, p < 0.01). There were no statistically significant differences in tissue adequacy, suitability for molecular analysis and sensitivity for malignancy and N2/N3 disease.The 22G Acquire TBNB needle procured improved quality tissue specimens compared to the Expect TBNA needle but this did not result in an improved the suitability rate for PD-L1 analysis.CONCLUSIONThe 22G Acquire TBNB needle procured improved quality tissue specimens compared to the Expect TBNA needle but this did not result in an improved the suitability rate for PD-L1 analysis. •The PD-L1 suitability rate between the 22G Acquire TBNB and Expect TBNA needle is similar.•Both needles have high sensitivities for diagnosing and staging lung cancer.•Acquire TBNB needle procures improved quality tissue specimens with more tissue cores. Endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) has an important role in the diagnosis and staging of lung cancer. Evaluation of programmed death ligand 1 (PD-L1) expression and molecular profiling has become standard of care but cytological samples frequently contain insufficient tumor cells. The 22G Acquire needle with Franseen needle tip was developed to perform transbronchial needle biopsy (TBNB) with improved tissue specimens. This study evaluated if the 22G Acquire TBNB needle results in enhanced PD-L1 suitability rate compared to the regular Expect 22G TBNA needle. in this multi-center randomized clinical trial (Netherlands Trial Register NL7701), patients with suspected (N)SCLC and an indication for mediastinal/hilar staging or lung tumor diagnosis were recruited in five university and general hospitals in the Netherlands, Poland, Italy and Czech Republic. Patients were randomized (1:1) between the two needles. Two blinded reference pathologists evaluated the samples. The primary outcome was PD-L1 suitability rate in patients with a final diagnosis of lung cancer. In case no malignancy was diagnosed, the reference standard was surgical verification or 6 month follow-up. 154 patients were randomized (n = 76 Acquire TBNB; n = 78 Expect TBNA) of which 92.9% (n = 143) had a final malignant diagnosis. Suitability for PD-L1 analysis was 80.0% (n = 56/70; 95 %CI 0.68–0.94) with the Acquire needle and 76.7% (n = 56/73; 95 %CI 0.65–0.85) with the Expect needle (p = 0.633). Acquire TBNB needle specimens provided more frequent superior quality (65.3% (95 %CI 0.57–0.73) vs 49.4% (95 %CI 0.41–0.57, p = 0.005) and contained more tissue cores (72.0% (95 %CI 0.60-0.81) vs 41.0% (95 %CI 0.31–0.54, p < 0.01). There were no statistically significant differences in tissue adequacy, suitability for molecular analysis and sensitivity for malignancy and N2/N3 disease. The 22G Acquire TBNB needle procured improved quality tissue specimens compared to the Expect TBNA needle but this did not result in an improved the suitability rate for PD-L1 analysis. |
| ArticleNumber | 107362 |
| Author | Cohen, Daniëlle von der Thüsen, Jan Kuijvenhoven, Jolanda C Trisolini, Rocco Ninaber, Maarten K Kramer, Tess Votruba, Jiri Korevaar, Daniël A Annema, Jouke T. Szlubowski, Artur Gnass, Maciej Hoppe, Bart Sestakova, Zuzana Bonta, Peter I |
| Author_xml | – sequence: 1 givenname: Tess orcidid: 0000-0002-2413-2329 surname: Kramer fullname: Kramer, Tess organization: Department of Respiratory Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands – sequence: 2 givenname: Jolanda C surname: Kuijvenhoven fullname: Kuijvenhoven, Jolanda C organization: Department of Respiratory Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands – sequence: 3 givenname: Jan surname: von der Thüsen fullname: von der Thüsen, Jan organization: Department of Pathology, Erasmus MC, Rotterdam, the Netherlands – sequence: 4 givenname: Daniëlle surname: Cohen fullname: Cohen, Daniëlle organization: Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands – sequence: 5 givenname: Artur surname: Szlubowski fullname: Szlubowski, Artur organization: Department of Respiratory Medicine, Pulmonary Hospital, Zakopane, Poland – sequence: 6 givenname: Maciej surname: Gnass fullname: Gnass, Maciej organization: Department of Respiratory Medicine, Pulmonary Hospital, Zakopane, Poland – sequence: 7 givenname: Maarten K surname: Ninaber fullname: Ninaber, Maarten K organization: Department of Respiratory Medicine, Leiden University Medical Center, Leiden, the Netherlands – sequence: 8 givenname: Bart surname: Hoppe fullname: Hoppe, Bart organization: Department of Respiratory Medicine, Leiden University Medical Center, Leiden, the Netherlands – sequence: 9 givenname: Rocco surname: Trisolini fullname: Trisolini, Rocco organization: Department of Respiratory Medicine, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy – sequence: 10 givenname: Zuzana surname: Sestakova fullname: Sestakova, Zuzana organization: Department of Respiratory Medicine, General University Hospital Prague, Prague, Czech Republic – sequence: 11 givenname: Jiri surname: Votruba fullname: Votruba, Jiri organization: Department of Respiratory Medicine, General University Hospital Prague, Prague, Czech Republic – sequence: 12 givenname: Daniël A surname: Korevaar fullname: Korevaar, Daniël A organization: Department of Respiratory Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands – sequence: 13 givenname: Peter I surname: Bonta fullname: Bonta, Peter I organization: Department of Respiratory Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands – sequence: 14 givenname: Jouke T. surname: Annema fullname: Annema, Jouke T. email: j.t.annema@amsterdamumc.nl organization: Department of Respiratory Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands |
| BookMark | eNqNUctOxCAUJUYTx8cnmLB00xHotLQaY0bjK5noRteEwm1lZEChNRk_wy-WyTgbN7qCnJwHnLOHtp13gNARJWNKaHkyH9vBdUq6MSMsTxjPS7aFRrTiLKvynG2jUeLVWUEI20V7Mc4JoZySeoS-rp32TfBOvRhp8WD7IKMfnMbGYW1k53w0rsMyIbGX3eruW7wKxClRQcDNEk_V-2ACYMZu8dPlwyX-gBCHiAN0g5Vhg0-xA9AW4ime4pAs_cJ8gsbKGmdUiu9DesQB2mmljXD4c-6j55vrp6u7bPZ4e381nWWqIHWfNbRUZcVqygqmdatl-nepGJXQ6rzVnPGJznUjG1kWGoo6J1zTakKAVTUF3uT76Hjt-xb8-wCxFwsTFVgrHfghClZxQid8QmiiFmuqCj7GAK14C2Yhw1JQIlYbiLn42UCsNhDrDZLu7JdOmV72xrtUs7F_qi_WakgtfBgIIioDqXOdula90N786XD-y2FT9Sss_6H_BjGDvY4 |
| CitedBy_id | crossref_primary_10_1080_17434440_2024_2410913 crossref_primary_10_1016_j_resinv_2024_08_016 crossref_primary_10_3390_jcm14051637 crossref_primary_10_1093_jjco_hyaf124 |
| Cites_doi | 10.1136/bmjopen-2021-051820 10.1111/crj.13063 10.1016/j.annonc.2019.10.026 10.1111/cyt.12795 10.1016/j.jasc.2020.04.009 10.1159/000346987 10.3390/cancers14205156 10.1007/s00595-020-01989-6 10.1016/j.rmed.2023.107131 |
| ContentType | Journal Article |
| Copyright | 2023 The Author(s) Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2023 The Author(s) – notice: Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved. |
| DBID | 6I. AAFTH AAYXX CITATION 7X8 |
| DOI | 10.1016/j.lungcan.2023.107362 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1872-8332 |
| ExternalDocumentID | 10_1016_j_lungcan_2023_107362 S0169500223009005 |
| GroupedDBID | --- --K --M .1- .55 .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29L 4.4 457 4CK 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABGSF ABJNI ABLJU ABMAC ABMZM ABUDA ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX AEBSH AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGRDE AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IHE J1W KOM M29 M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SEL SES SEW SPCBC SSH SSU SSZ T5K UDS WUQ X7M Z5R ZGI ~G- ~HD 6I. AACTN AAFTH AFCTW AFKWA AJOXV AMFUW RIG 9DU AAYXX CITATION 7X8 |
| ID | FETCH-LOGICAL-c509t-b16c68291252ddfda1076c21aefd3fd7274d3dbaba65de59307d1840e2891e7b3 |
| ISICitedReferencesCount | 6 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001100137300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0169-5002 1872-8332 |
| IngestDate | Thu Oct 02 04:10:35 EDT 2025 Sat Nov 29 07:29:01 EST 2025 Tue Nov 18 21:34:46 EST 2025 Tue Dec 03 03:44:48 EST 2024 Tue Oct 14 19:27:49 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Cytopathology Programmed death ligand 1 Endobronchial ultrasound Transbronchial needle aspiration Lung cancer |
| Language | English |
| License | This is an open access article under the CC BY license. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c509t-b16c68291252ddfda1076c21aefd3fd7274d3dbaba65de59307d1840e2891e7b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-2413-2329 |
| OpenAccessLink | https://dx.doi.org/10.1016/j.lungcan.2023.107362 |
| PQID | 2870147401 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2870147401 crossref_primary_10_1016_j_lungcan_2023_107362 crossref_citationtrail_10_1016_j_lungcan_2023_107362 elsevier_sciencedirect_doi_10_1016_j_lungcan_2023_107362 elsevier_clinicalkey_doi_10_1016_j_lungcan_2023_107362 |
| PublicationCentury | 2000 |
| PublicationDate | November 2023 2023-11-00 20231101 |
| PublicationDateYYYYMMDD | 2023-11-01 |
| PublicationDate_xml | – month: 11 year: 2023 text: November 2023 |
| PublicationDecade | 2020 |
| PublicationTitle | Lung cancer (Amsterdam, Netherlands) |
| PublicationYear | 2023 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Livi, Sotgiu, Cancellieri, Paioli, Leoncini, Magnini, Trisolini (b0045) 2022; 14 Hendry, Byrne, Christie, Steinfort, Irving, Wagner (b0015) 2020; 31 Oki, Saka, Kitagawa, Kogure, Murata, Adachi, Ando (b0040) 2013; 85 Mineura, Hamaji, Yoshizawa, Nakajima, Kayawake, Tanaka, Yamada, Yutaka, Nakajima, Ohsumi, Menju, Chen-Yoshikawa, Date (b0025) 2020; 50 Park, Vansteenkiste, Lee, Pentheroudakis, Zhou, Prabhash, Seto, Voon, Tan, Yang, Wang, Babu, Nakayama, Alip, Chua, Cheng, Senan, Ahn, Kim, Ahn, Peters, Yoshino, Douillard (b0005) 2020; 31 Balwan, Bixby, Grotepas, Witt, Iravani, Ansari, Reddy (b0035) 2020; 9 Aboudara, Saettele, Tawfik (b0030) 2023; 208 Livi, Ardizzoni, Cancellieri, Natali, Ferrari, Paioli, De Biase, Capizzi, Tallini, Fiorentino, Trisolini (b0020) 2019; 13 Kuijvenhoven JC, Kramer T, Korevaar DA, Ninaber MK, Trisolini R, Szlubowski A, et al. Endobronchial ultrasound in diagnosing and staging of lung cancer by Acquire 22G TBNB versus regular 22G TBNA needles: study protocol of a randomised clinical trial. BMJ Open. 2021;11(9):e051820. Livi (10.1016/j.lungcan.2023.107362_b0020) 2019; 13 Balwan (10.1016/j.lungcan.2023.107362_b0035) 2020; 9 10.1016/j.lungcan.2023.107362_b0010 Hendry (10.1016/j.lungcan.2023.107362_b0015) 2020; 31 Mineura (10.1016/j.lungcan.2023.107362_b0025) 2020; 50 Livi (10.1016/j.lungcan.2023.107362_b0045) 2022; 14 Park (10.1016/j.lungcan.2023.107362_b0005) 2020; 31 Oki (10.1016/j.lungcan.2023.107362_b0040) 2013; 85 Aboudara (10.1016/j.lungcan.2023.107362_b0030) 2023; 208 |
| References_xml | – volume: 31 start-page: 90 year: 2020 end-page: 95 ident: b0015 article-title: Adequate tumour cellularity is essential for accurate PD-L1 immunohistochemistry assessment on cytology cell-block specimens publication-title: Cytopathology – volume: 50 start-page: 1049 year: 2020 end-page: 1055 ident: b0025 article-title: Diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration to assess tumor-programmed cell death ligand-1 expression in mediastinal lymph nodes metastasized from non-small cell lung cancer publication-title: Surgery Today – volume: 9 start-page: 249 year: 2020 end-page: 253 ident: b0035 article-title: Core needle biopsy with endobronchial ultrasonography: single center experience with 100 cases publication-title: J Am Soc Cytopathol. – volume: 85 start-page: 486 year: 2013 end-page: 492 ident: b0040 article-title: Rapid on-site cytologic evaluation during endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing lung cancer: a randomized study publication-title: Respiration – volume: 14 start-page: 5156 year: 2022 ident: b0045 article-title: Ultrasound-Guided needle aspiration biopsy of superficial metastasis of lung cancer with and without rapid On-Site evaluation: A randomized trial publication-title: cancers (Basel) – reference: Kuijvenhoven JC, Kramer T, Korevaar DA, Ninaber MK, Trisolini R, Szlubowski A, et al. Endobronchial ultrasound in diagnosing and staging of lung cancer by Acquire 22G TBNB versus regular 22G TBNA needles: study protocol of a randomised clinical trial. BMJ Open. 2021;11(9):e051820. – volume: 208 year: 2023 ident: b0030 article-title: Endobronchial ultrasound bronchoscopy franseen fine needle biopsy tool versus standard fine needle aspiration needle: Impact on diagnosis and tissue adequacy publication-title: Respiratory Medicine – volume: 13 start-page: 590 year: 2019 end-page: 597 ident: b0020 article-title: Adequacy of endosonography-derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer publication-title: The Clinical Respiratory Journal – volume: 31 start-page: 191 year: 2020 end-page: 201 ident: b0005 article-title: Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS publication-title: SSO and TOS. Ann Oncol. – ident: 10.1016/j.lungcan.2023.107362_b0010 doi: 10.1136/bmjopen-2021-051820 – volume: 13 start-page: 590 issue: 9 year: 2019 ident: 10.1016/j.lungcan.2023.107362_b0020 article-title: Adequacy of endosonography-derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer publication-title: The Clinical Respiratory Journal doi: 10.1111/crj.13063 – volume: 31 start-page: 191 issue: 2 year: 2020 ident: 10.1016/j.lungcan.2023.107362_b0005 article-title: Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS publication-title: SSO and TOS. Ann Oncol. doi: 10.1016/j.annonc.2019.10.026 – volume: 31 start-page: 90 issue: 2 year: 2020 ident: 10.1016/j.lungcan.2023.107362_b0015 article-title: Adequate tumour cellularity is essential for accurate PD-L1 immunohistochemistry assessment on cytology cell-block specimens publication-title: Cytopathology doi: 10.1111/cyt.12795 – volume: 9 start-page: 249 issue: 4 year: 2020 ident: 10.1016/j.lungcan.2023.107362_b0035 article-title: Core needle biopsy with endobronchial ultrasonography: single center experience with 100 cases publication-title: J Am Soc Cytopathol. doi: 10.1016/j.jasc.2020.04.009 – volume: 85 start-page: 486 issue: 6 year: 2013 ident: 10.1016/j.lungcan.2023.107362_b0040 article-title: Rapid on-site cytologic evaluation during endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing lung cancer: a randomized study publication-title: Respiration doi: 10.1159/000346987 – volume: 14 start-page: 5156 issue: 20 year: 2022 ident: 10.1016/j.lungcan.2023.107362_b0045 article-title: Ultrasound-Guided needle aspiration biopsy of superficial metastasis of lung cancer with and without rapid On-Site evaluation: A randomized trial publication-title: cancers (Basel) doi: 10.3390/cancers14205156 – volume: 50 start-page: 1049 issue: 9 year: 2020 ident: 10.1016/j.lungcan.2023.107362_b0025 article-title: Diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration to assess tumor-programmed cell death ligand-1 expression in mediastinal lymph nodes metastasized from non-small cell lung cancer publication-title: Surgery Today doi: 10.1007/s00595-020-01989-6 – volume: 208 year: 2023 ident: 10.1016/j.lungcan.2023.107362_b0030 article-title: Endobronchial ultrasound bronchoscopy franseen fine needle biopsy tool versus standard fine needle aspiration needle: Impact on diagnosis and tissue adequacy publication-title: Respiratory Medicine doi: 10.1016/j.rmed.2023.107131 |
| SSID | ssj0017109 |
| Score | 2.4392283 |
| Snippet | •The PD-L1 suitability rate between the 22G Acquire TBNB and Expect TBNA needle is similar.•Both needles have high sensitivities for diagnosing and staging... Endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) has an important role in the diagnosis and staging of lung cancer. Evaluation of... |
| SourceID | proquest crossref elsevier |
| SourceType | Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 107362 |
| SubjectTerms | Cytopathology Endobronchial ultrasound Lung cancer Programmed death ligand 1 Transbronchial needle aspiration |
| Title | Endobronchial ultrasound in diagnosing and staging of lung cancer by Acquire 22G TBNB versus regular 22G TBNA needles: A randomized clinical trial |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0169500223009005 https://dx.doi.org/10.1016/j.lungcan.2023.107362 https://www.proquest.com/docview/2870147401 |
| Volume | 185 |
| WOSCitedRecordID | wos001100137300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1872-8332 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017109 issn: 0169-5002 databaseCode: AIEXJ dateStart: 19950401 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3JbtswECWcpCh6Kbqi6RKwQG-CXJta2ZscuEuaGj24hW8CJdKJDUUK5AVpP6O_2B_pjEhJjrskOfQiGIRJUZwnztPwDUnIKxYkDDibtJGe2m6iuM2VACLHQ98JgPSrKivt63EwGoWTCf_c6fysc2HWWZDn4cUFP_-vpoYyMDamzt7A3E2jUAC_wehwBbPD9VqGH-aySMoiRxFzZq2yZSkWeHZSpXvVwro6MRGY4YlRPWcrTL5FCJTISKMUFcLKYuydNR6MBhaqN1a4xHBS6VZNeWTl4P2Mri6ywO_J4mz2HUhsk3FZHQuySYGPN-4E9DY6w60apMFlm368EaL4iAIyjaxaL1ItPs3mMFOfFmuTX1JgPdGGfdcFCn1La3yKaoDBoYk1HbXvQ5Obgon2lWRgkJnBNIEQ5piMwI3YqM9tr9fbmty9jekZvnUdPfn_5jl0EGPexeGGMejiHbrt_y_v1L3lQRtdYy2Zm8emmRibiXUzO2SPBR6HqXcv-jCcHDWLXSiH1VvQ6_63iWav_9ifv1GoLTJRMaTxPXLXfNrQSEPyPumo_AG5_cmINx6SH5eQSVtk0llOW2RSsCI1yKTFlGLXqMYLTb5Rg0wKCKSITKqRSQ0y6_KIGmS-oRFtcUlrXNIKl4_Il7fD8eF72xwJYqfAbJd20vdTP2QcaDmTcioFjIifsr5QU-lMJZBxVzoyEYnwPak8Dh5MYgxDsZD3VZA4j8luXuTqCaFSpS5PQxWInuP2JE-UJ0RPTFkvlC5LxD5x61GOU7NfPh7bksX_tPI-6TbVzvWGMVdV8GsTxvUYgP-OAZhXVQybioYuaxp8naova6zE4E5wjVDkqlgtYtQ99F08pvPpTR_kGbnTvpbPye6yXKkX5Fa6Xs4W5QHZCSbhgYH-L1H78B0 |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Endobronchial+ultrasound+in+diagnosing+and+staging+of+lung+cancer+by+Acquire+22G+TBNB+versus+regular+22G+TBNA+needles%3A+A+randomized+clinical+trial&rft.jtitle=Lung+cancer+%28Amsterdam%2C+Netherlands%29&rft.au=Kramer%2C+Tess&rft.au=Kuijvenhoven%2C+Jolanda+C&rft.au=von+der+Th%C3%BCsen%2C+Jan&rft.au=Cohen%2C+Dani%C3%ABlle&rft.date=2023-11-01&rft.issn=0169-5002&rft.volume=185&rft.spage=107362&rft_id=info:doi/10.1016%2Fj.lungcan.2023.107362&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_lungcan_2023_107362 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0169-5002&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0169-5002&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0169-5002&client=summon |